Jump to content

Search the Community

Showing results for tags 'neuroscience'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Welcome Center
    • Getting Started
    • New From Neuronline!
    • Help Desk
  • Virtual Events
    • Extended Discussion
    • Event Recaps
    • Live Chats
  • Scientific Research and Training
    • Scientific Research Discussion
    • Neurobiology of Disease Workshop
    • Optogenetics Training Series
    • Program Development
  • Career Discussions
    • Professional Development
    • Career Advice
    • Career Paths
    • Career Stage
  • Diversity
    • Diversity Discussion
    • International Experiences
  • Outreach and Advocacy
    • Outreach and Advocacy Discussion
    • Brain Awareness & Teaching
    • Animals in Research
  • Foundations of Rigorous Neuroscience
    • Foundations of Rigorous Neuroscience
  • COVID-19 Resources
    • Online Learning and Teaching Tools
    • Lab Management and Research
  • Archive
    • SfN Global Connectome: A Virtual Event
    • Archive
    • Past Annual Meetings
  • Support
  • SfN Chapters's Topics
  • Press Conference's Topics

Product Groups

There are no results to display.

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...

Found 9 results

  1. Check-a-look at this neuroscience and art collaboration exhibit at the international Mozilla Festival 2021! This exhibit features 11 contemporary pieces of art exploring neuroscience themes. https://www.convergenceinitiative.org/convergencemozillaexhibition Thank you Cristian Zaelzer for sharing!
  2. Andrew Chen

    Neuroscience 2020 Cancelled

    Full news release Neuroscience 2020, scheduled for October 24-28, 2020 in Washington, D.C. has been cancelled. The ongoing COVID-19 pandemic has made it impossible to safely move forward with the meeting this year. We also are planning virtual opportunities in 2021, with a focus on a virtual experience in early winter 2021. More details will be made available as soon as possible. Additionally, current on-demand SfN member virtual programming can be accessed via Neuronline. We recognize that 2020 has been an extraordinarily difficult time, and we hope that SfN members and their families, volunteers, exhibitors, and all others stay as safe and healthy as possible. With many labs still closed or operating at reduced capacity, the loss of in-person scientific exchange, and an uncertain job market for trainees, SfN recognizes the need to envision new roles and avenues by which the Society can continue to serve the membership and the field during this unprecedented time.
  3. On July 2 at 12 p.m. EDT, members of SfN and the neuroscience community will be hosting a panel discussion called “Black Lives Matter and Neuroscience: Why This Moment Matters.” The discussion will be moderated by @Joanne_Berger_Sweeney, PhD, and will feature @nii_addy, PhD, @Marguerite Matthews, PhD, and @Fitzroy Wickham. During the discussion, our panelists will speak about challenges diverse neuroscientists face within the field and provide guidance on how the neuroscience community can leverage this moment to influence change. Additionally, the panel will discuss the impact of COVID-19 on the tenure clock for junior faculty, and how that impacts faculty of color. Neuroscientists of all backgrounds are encouraged to attend and contribute to the discussion. Learn more and register for this webinar on Neuronline. The panelists will also be available to chat with in this thread after the webinar has concluded and will continue the conversations stemming from the webinar.
  4. until
    Neuroscience is stronger with diverse perspectives. Although there have been gains in the percentage of underrepresented neuroscience researchers in recent years, there is still more work to be done to increase representation of diverse researchers and to create inclusive and equitable research environments. On July 2nd, 12:00 – 1:00 pm EDT, SfN will host a panel discussion called, “Black Lives Matter and Neuroscience: Why this moment matters.” The discussion will be moderated by Joanne Berger-Sweeney, PhD, and will feature Nii Addy, PhD, Marguerite Matthews, PhD, and Fitzroy ‘Pablo’ Wickham. During the discussion, our panelists will speak about challenges diverse neuroscientists face within the field and provide guidance on how the neuroscience community can leverage this moment to influence change. Additionally, the panel will discuss the impact of COVID-19 on the tenure clock for junior faculty, and how that impacts faculty of color. Neuroscientists of all backgrounds are encouraged to attend and contribute to the discussion. Register for this event on Neuronline. This event is free and open, so please share with your neuroscience network outside of SfN.
  5. Cognition Therapeutics sponsored a satellite symposium with a panel of expert speakers from the global sigma-2 community whose presentations aimed to advance our understanding of the molecular identity of the sigma-2 radioligand binding site, its protein interactions, the functional roles of the sigma-2 receptor in cellular and synaptic signaling and report clinical trial outcomes of a sigma-2 antagonist in Alzheimer’s disease patients. Speakers included Drs. Wayne Bowen of Brown University, Michael Cahill of Charles Sturt University, Timothy Kennedy of McGill University, Tara Spires-Jones of the University of Edinburgh, Stephen Martin of the University of Texas at Austin, Sonny Singh of the University of North Texas, Robert Mach and two of his colleagues, Aladdin Riad and Chenbo Zeng of the University of Pennsylvania, as well as Drs. Izzo and Catalano from Cognition Therapeutics. This is an exceptional group of researchers and the discussion was extremely fruitful. Several abstracts were presented by these researchers at SFN2018 that disclosed major unpublished scientific information about molecular mechanisms and therapeutic clinical trial results of significance to the entire neuroscience community. To learn more, please peruse these videos. Video archives are as follows: Introduction to Session and Speakers Susan Catalano, Ph.D., Chief Science Officer and Founder Cognition Therapeutics, Inc. Differential Sigma-2 Receptor/TMEM97-Mediated Cytotoxic and Metabolic Stimulative Properties of Monovalent and Bivalent SN79 Analogs Wayne D. Bowen, Ph.D. Upjohn Professor of Pharmacology Professor of Biology Chair of the Department of Molecular Pharmacology, Physiology & Biotechnology Brown University Targeting Sigma-2 Receptor (σ2R)/TMEM97 to Address Unmet Medical Needs in Neuroscience Stephen F. Martin, Ph.D. M. June and J. Virgil Waggoner Regents Chair in Chemistry University of Texas at Austin Sigma 2 Receptor-Interacting Protein PGRMC1 is Descended from the Hopanoid Synthetic Pathway of the Endosymbiotic Proto-Mitochondrion Michael A. Cahill, Ph.D. Lecturer in Biochemistry and Cell Biology Charles Sturt University, New South Wales, Australia Let7i as a Key Regulator of PGRMC1 and Progesterone-Induced Neuroprotection Meharvan “Sonny” Singh, Ph.D. Professor, Department of Pharmacology and Neuroscience Interim Executive Director, Institute for Healthy Aging University of North Texas Health Science Center Clinical Evidence of Synaptic Protection in Alzheimer’s Patients following Treatment of CT1812 Susan Catalano, Ph.D. Chief Science Officer and Founder Cognition Therapeutics, Inc. Sigma-2 Antagonist CT1812 Protects Synapses from Abeta Oligomer-Induced Loss, In Vitro Nicholas J. Izzo, Ph.D. Principal Scientist and Director of Screening Cognition Therapeutics, Inc. APOE4 Associated Changes in the Synaptic Proteome in Human Alzheimer’s Disease Brain Tara Spires-Jones, DPhil Professor of Neurodegeneration UK Dementia Research Institute Programme Lead Deputy Director of the Centre for Discovery Brain Sciences University of Edinburgh, Scotland The Essential Role of Sigma-2 Receptor/TMEM97 and Progesterone Receptor Membrane Component 1 in the Internalization of Low-Density Lipoprotein via and Interaction with the Low-Density Lipoprotein Receptor Aladdin A. Riad, Ph.D. Postdoctoral Fellow University of Pennsylvania A Novel Mechanism Underlying Synaptic Plasticity: Roles for PGRMC1 and TMEM97? Timothy E. Kennedy, Ph.D. co-Director, McGill Program in Neuroengineering Professor, Department of Neurology and Neurosurgery Professor, Department of Anatomy and Cell Biology Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada Biological Roles of TMEM97 and PGRMC1 in Cell Growth and Sigma-2 Ligand-Induced Cell Death Chenbo Zeng, Ph.D. Research Assistant Professor of Radiology University of Pennsylvania Identification of a Second [3H]DTG Binding Site on TMEM97-KO Cell Membranes Robert H. Mach, Ph.D. Britton Chance Professor of Radiology University of Pennsylvania
  6. For those of you interested in music therapy and neuroscience as well as music and brain health, please consider attending the Music Therapy Conference - Healthy, Music, and Communication at Northwestern University on Friday, May 11th from 8:30 am to 5:00 pm. Here is the link for more information: https://musictherapy.soc.northwestern.edu Hope to see you there!
  7. As a chemistry graduate student, I feel that I may be the needle in a haystack at SfN. I study the global metabolomics of brain chemistry. Currently, I have detected over 100 compounds from homogenized tissue and ~60 compounds from dialysate. Since my research isn’t focused on studying a single metabolite, I wanted to hear from the SfN community about their favorite neurotransmitter/modulator and why? Please include specifics about the molecules function within the brain, and to what region of the brain. Look forward to your responses. -The Alchemist
  8. https://spectrumnews.org/features/special-report/notable-papers-2016/ The article from Spectrum did a nice job summarizing notable papers of 2016 in the ASD world. It includes links to the original publications.
  9. As an aspiring HS student approaching senior year, I am faced with many options on how to reach my dreams. I still am torn between clinical or research neuro (though slightly leaning towards research, specifying in cellular/molecular aspects especially). The schools I have been looking into either provide neuroscience as an undergrad major or pre-med, which then afterwards I could go into grad school or medical school to continue my studies (clinical v research). My question is that what would be the difference in these approaches, and what I could do with each pathway. Also, what would be the difference between having an MD vs PhD, I understand that a the first can be a physician, however, what can someone with a PhD do?
  • Create New...